SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Centocor ( CNTO ) -- Ignore unavailable to you. Want to Upgrade?


To: Mark Oliver who wrote (729)6/29/1998 1:44:00 PM
From: PawPr  Read Replies (1) | Respond to of 965
 
The advisory panel RECOMMENDED clearance last month. The full FDA can act on that recommendation anytime thereafter; the time frame is unpredictable, and I'm not aware of anything specific to be announced tomorrow. They usually, but not always, follow the advisory panel's advice. ( For example, the panel voted against CORR's heart drug, yet the FDA approved it anyway ).